A61P 5/46
For decreasing, blocking or antagonising the activity of glucocorticosteroids
Official title: for decreasing, blocking or antagonising the activity of glucocorticosteroids
A61P5/46 (For decreasing, blocking or antagonising the activity of glucocorticosteroids) appears on 220 US grants and 322 published applications in this corpus.
Search patents in A61P- Granted patents
- 220
- Published applications
- 322
- Assignees
- 137
- Inventors
- 629
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 4 | 4 |
| 2003 | 3 | 11 |
| 2004 | 4 | 21 |
| 2005 | 2 | 14 |
| 2006 | 9 | 20 |
| 2007 | 13 | 18 |
| 2008 | 10 | 9 |
| 2009 | 8 | 26 |
| 2010 | 11 | 19 |
| 2011 | 7 | 14 |
| 2012 | 18 | 14 |
| 2013 | 19 | 16 |
| 2014 | 12 | 10 |
| 2015 | 10 | 20 |
| 2016 | 10 | 13 |
| 2017 | 10 | 12 |
| 2018 | 7 | 13 |
| 2019 | 13 | 10 |
| 2020 | 11 | 11 |
| 2021 | 6 | 9 |
| 2022 | 7 | 6 |
| 2023 | 3 | 8 |
| 2024 | 7 | 9 |
| 2025 | 3 | 7 |
| 2026 | 3 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating glucocorticoid excess15 Sep 2026US 12,734,155 B2Sparrow Pharmaceuticals, Inc.
- Methods and compositions for treating glucocorticoid excess15 Sep 2026US 12,734,156 B2Sparrow Pharmaceuticals, Inc.
- 3-phenylpropylamine derivative21 Apr 2026US 12,606,533 B2Daiichi Sankyo Company, Limited
- Stabilized modified release vitamin D formulation and method of administering same25 Nov 2025US 12,478,631 B2Eirgen Pharma Ltd.
- Methods of treating disease with levoketoconazole5 Aug 2025US 12,377,096 B2Xeris Pharmaceuticals, Inc.
- Methods and compositions for treating hsd-1-mediated disorders30 Jul 2026US 2026/0217663 A1
- Methods and compositions for treating glucocorticoid excess21 May 2026US 2026/0137656 A1Sparrow Pharmaceuticals, Inc.
- Methods and compositions for treating glucocorticoid excess21 May 2026US 2026/0137657 A1Sparrow Pharmaceuticals, Inc.
- Methods and compositions for treating glucocorticoid excess21 May 2026US 2026/0137658 A1Sparrow Pharmaceuticals, Inc.
- Methods and compositions for treating glucocorticoid excess21 May 2026US 2026/0137659 A1Sparrow Pharmaceuticals, Inc.
Most cited
By later US patents
- ActRII receptor polypeptides, methods and compositions121US 7,709,605 B2Acceleron Pharma Inc. · 2010
- Quick release pharmaceutical compositions of drug substances113US 6,713,089 B1Nycomed Danmark A/S · 2004
- Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein92US 6,756,480 B2Amgen Inc. · 2004
- Actriib-Fc polynucleotides, polypeptides, and compositions83US 8,252,900 B2Acceleron Pharma Inc. · 2012
- 4-aminopiperidine and their use as a medicine74US 7,115,634 B2Societe de Conseils de Recherches et d' Applications Scientifiques · 2006